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Abstract 
We have studied the inhibition by a phosphorothioate ohgodeoxynucleotide (17PScap) of cDNA synthesis performed by either avian or murine 
reverse transcrintase. Three different mechanisms of inhibition were identified: at low concentrations (cl00 nM). the cleavage of the RNA template 
by the retroviral RNase H at the level of the RNAI17PScap duplex accounted for most of the effect, whereashybrid-arrested cDNA synthesis by 
an RNase H-independent mechanism marginally contributed to the inhibition. Both mechanisms were sequence-specific. Above 100 nM, the overall 
cDNA synthesis was reduced in a non-specific manner. 
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1. Introduction 
Many studies have been devoted to the effect of anti- 
sense oligonucleotides on the expression of a gene [l]. 
Targets for these oligonucleotides can be of different 
origin: endogenous mRNAs or pre-RNAs of eukaryotes, 
microinjected mRNAs, or viral RNAs. Consequently, 
antisense oligonucleotides are potential inhibitors of vi- 
ruses, by interfering with one or more of their develop- 
mental steps (splicing, translation or reverse transcrip- 
tion). Due to the urgent need for active drugs against 
AIDS, particular attention has been paid to HIV. Phos- 
phorothioate (PS) oligonucleotides have been widely 
studied, as they can inhibit HIV multiplication in cul- 
tured cells with a higher efficacy than unmodified 
phosphodiester (PO) ones 12-71. This difference is partly 
due to their increased resistance to nucleases in culture 
media [8], and more critically to their mechanism of 
inhibition: in contrast to PO oligonucleotides which dis- 
play essentially specific effects, both sequence-dependent 
(antisense) and -independent activities have been re- 
ported for PS derivatives. In chronically infected cells. 
the inhibition is length- and sequence-dependent: PS 
oligonucleotides complementary to different regions of 
*Corresponding author. Fax: (33) 57 57 10 15. 
Abbreviatrons: RT, reverse transcriptase; RNase H, ribonuclease H; 
AMV, avian myeloblastosis virus; MMLV, Moloney murine leukemia 
virus: MMLV H- RT, MMLV RT devoid of RNase H activity; HIV, 
human immunodeficiency virus: PS, phosphorothioate; PO, phospho- 
diester: nt. nucleotide. 
HIV RNA block viral replication following binding to 
their target sequence. Non-complementary (mismatched 
or random) oligonucleotides delay but do not completely 
inhibit HIV replication [9,10]. In these conditions, PS 
oligonucleotides seem to interfere with viral mRNA 
translation by an antisense mechanism [7]. In contrast, 
the inhibition of HIV in de novo infected cells by PS 
oligonucleotides is related more to their length than to 
their sequence. A homocytidine 28-mer, S-dC28, was 
demonstrated to interfere with the binding of gp120 to 
CD4 [ll]; in addition, PS oligonucleotides have a great 
affinity for HIV reverse transcriptase (RT) [12]. 
Reverse transcription, which is an early event in retro- 
viral infection, is an attractive step to target with anti- 
HIV drugs. The inhibition of cDNA synthesis would 
prevent the pro-viral DNA integration in the host 
genome. The antisense strategy is worth considering for 
this purpose. Several studies have already been published 
on the in vitro inhibition of reverse transcription by an- 
tisense oligonucleotides. On the one hand, an RNase 
H-mediated cleavage, generating a truncated RNA ma- 
trix, was demonstrated to be involved in the inhibition 
by unmodified oligonucleotides [13,14]. On the other 
hand, physical blocking was observed with oligonucleo- 
tides leading to a covalent linkage to the target [15], or 
with unreactive oligonucleotides [ 13,16,17]. The wide use 
of PS oligonucleotides to control HIV development 
prompted us to study the inhibition of reverse transcrip- 
tion of an RNA template by a PS oligonucleotide. In a 
previous report, we have shown that antisense PS ol- 
igonucleotides could be used as selective inhibitors of 
cDNA synthesis [18]. The results described in this paper 
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extend this study and shed some light on the mechanism 
and on the efficacy of this process. 
2. Materials and Methods 
2.1 Oligonucleotides 
Unmodified and phosphorothioate oligodeoxynucleotides (see Table 
1 for sequences) were synthesized on a Millipore 7500 automated syn- 
thesizer, using the conventional phosphoramidite method, except hat, 
for the phosphorothioate oligomer, the oxidation step was substituted 
by a sulfurization procedure using home-made Beaucage’s reagent 1191. 
Ghgodeoxynucleotides were usually purified in one step by HPLC on 
a reverse phase column eluted by an acetonitrile gradient (048%) in 
a 100 mM ammonium acetate (pH 7.0) buffer. For analysis, unmodified 
and phosphorothioate ohgomers were 5’ end-labelled with [y-‘*P]ATP 
and T4 polynucleotide kinase according to standard procedures [20]. 
The purity of the oligomers was evaluated by running ‘*P-labelled 
samples on a 20% polyacrylamidel7 M urea gel. 
2lRNAsense (Table 1) was synthesized by transcription with T7 
RNA polymerase as described by Milligan et al. [21], and purified by 
preparative gel electrophoresis [22]. Some oligodeoxynucleotides were 
purified similarly. 
2.2. RNA template and enzymes 
T4 polynucieotide kinase was from Boehringer, E. coli RNase H 
from Promeea. and AMV RT from AnDhgene. MMLV and MMLV 
H- RTs, as \;ell as rabbit globin mRN& w&e purchased from Gibco 
BRL. T7 RNA polymerase was prepared from an over-producing 
strain (BL21/pAR1219) according to a previously published procedure 
[23]. 
,&Globin mRNA was used as a template for reverse transcription with- 
out any treatment. An RNA fragment, about 160 nucleotides long, 
prepared for Northern blot analysis, was produced by oligonucleotide- 
directed cleavage of rabbit /I-globin mRNA by RNase H: 1 fig of globin 
mRNA was incubated with 10 U of E. coli RNase H, in the presence 
of 100 pmol of 15-mer‘cleavage’ complementary to nucleotides 147-161 
of the /7-globin message (Table 1). The reaction was performed for 2 h 
at 37°C. in 20 ~1 of a 20 mM Tris-HCl, pH 7.5, buffer containing 
IO mM MgCl,, 100 mM KC1 and 0.1 mM dithiothreitol. At the end of 
the incubation, RNA was phenol-extracted, ethanol-precipitated and 
dissolved in 25 ~1 of sterile water. For reverse transcription, one tenth 
of the RNA solution (corresponding to 0.25 pmol/3-globin mRNA) was 
used in each reaction as described below. 
2.3. Reverse transcriptron 
The standard reaction for cDNA synthesis was performed as follows: 
either 100 ng globin mRNAs corresponding to 0.25 pmol of /I-globin 
mRNA (for cDNA analysis) or 0.25 pmol of the 160 nt RNA fragment 
(for RNA template analysis), 10 pmol of primer (Ill-mer’primer’ except 
where indicated) and the desired amount of antisense oligodeoxynucle- 
otide were pre-incubated for 20 min at 39°C in 8 ~1 of a solution 
containing 100 mM Tris-HCI, pH 8.3,72 mM KCI, 10 mM MgCI, and 
10 mM dithiothreitol. After addition of 2 ~1 of the same solution 
containing 1 nmol of each of the four dXTPs and 2 pmol of [a-32P]dCTP 
(111 TBq/mmol; Du Pont de Nemours) and 1 U AMV RT, 50 U 
MMLV RT or SO U MMLV H- RT (final concentrations of about 17. 
180 and 600 nM, respectively), the reaction was performed for either 
15 min (RNA analysis) or 1 h @DNA analysis) at 39°C. The products 
of the reverse transcription were chloroform-extracted, ethanol-precip- 
itated according to standard procedures [20] and loaded on a 10% 
polyacrylamide/7 M urea gel. The yield of cDNA synthesis was deter- 
mined by counting the radioactivity of gel slices in a j?-scintillator 
counter. 
2.5. Analysis of hybrid stability 
Melting curves of RNA/oligonucleotide duplexes were obtained as 
follows: the 2lRNAsense and either 17POcap or 17PScap (1 PM each) 
were tnixed in a 10 mM sodium cacodylate, pH 7.0, buffer containing 
50 mhl NaCl and 1 mM magnesium acetate. UV absorbance was 
continuously recorded at 260 nm on a Uvikon 930 spectrometer, in a 
1 cm quartz cuvette, while the temperature was increased from 20°C 
to 95’C, at 3O”CYh. The melting temperatures (T,,,) were deduced from 
the curves. 
3. Results 
3.1. A phosphorothioate oligonucleotide blocks reverse 
transcription via an antisense mechanism 
/?-Globin mRNA was used as a template to direct 
reverse transcription by AMV or MMLV RTs, primed 
by a 17-mer complementary to nt 113-129 of mRNA 
(Table 1). As shown in Fig. 1, this produced the expected 
129 nt long cDNA product. Addition of different con- 
centrations of the antisense phosphorothioate oligonu- 
cleotide, 17PScap, or of the phosphodiester homologous 
sequence, 17POcap, reduced the amount of the full- 
length cDNA and generated shorter fragments, the 
length of which (about 110 nt) corresponded to an arrest 
of polymerization at, or close to, the 5’ end of the RNA- 
bound antisense oligonucleotide. The use of 15- 
mer‘primer’ complementary to nt 34-48 of the RNA 
template (see Table l), which generated a shorter cDNA, 
allowed a more precise mapping of the 3’ end of the 
cDNA products in the presence of antisense oligonucleo- 
tides. The stop sites were located at the same positions 
for 17POcap and 17PScap, and corresponded to the first 
and third base pairs of the hybrid (from the 5’ end of the 
oligonucleotide) with the AMV RT, and to the first and 
second base pairs with the MMLV RT (not shown). 
Table 1 
The sequence of ohgonucleotides used throughout his study 
Name 
DNA 
Sequence Target 
17POcapll7PScap 
17-mer’primer’ 
15-m&primer’ 
17-mer‘probe’ 
15-m&cleavage’ 
TTGTGTCAAAAGCAAGT 3-19 
CACCAACTTCTTCCACA 113-129 
CTGTTTTGGGGGATT 3448 
GACAGATGCACCATTCT 51-67 
GTAGACAACCAGCAG 147-161 
RNA 
2 1 RNAsense GGCACUUGCUUUUGACACAAC 
2.4. Northern blot analysis of the RNA template 
After reverse transcription (15 min), the RNA was chloroform- 
extracted and ethanol-precipitated. It was then loaded on a 10% poly- 
acrylamide gel containing 7 M urea and electroblotted on to a nylon 
membrane (Pall) according to the supplier’s instructions. Blots were 
revealed with the 32P 5’ end-labelled 17-mer‘probe’. Quantitative valu- 
ation of cleavage was performed by densitometric analysis. 
The sequences are given in the 5’ (left) to the 3’ (right) direction, The 
corresponding abbreviation is given to the left, and the location of the 
target on rabbit &globin mRNA to the right (+I is the first nt after the 
7-methylguanosine r sidue [27]). The sequence of 21RNAsense is simi- 
lar to the sense 2-20 sequence, except that two extra G’s were added 
at the 5’ end to improve the transcription efficacy. 
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Enzyme : AMV MMLV 
Anllsense : - 17IPScap 17POcap - 17PScap 17POcap 
M 30 150 30 150 30 150 30 150 
147 - 
I 4 
Fig. 1. Effect of antisense oligonucleotides on reverse transcription. 
cDNA synthesis performed either by AMV (left) or MMLV (right) 
RTs, in the absence (-) or presence of 30 and 150 nM 17PScap or 
17POcap, was initiated by 17-mer‘primer’. M is the size marker in nt. 
3.2. The antisense oligonucleotides 17PScap and 
17POcap inhibit reverse transcription with similar 
efJiciencies 
We quantified the relative cDNA synthesis of the trun- 
cated 110 nt long fragments. Results obtained with the 
AMV (Fig. 2a) or the MMLV RT (Fig. 2b) showed that 
17PScap was slightly less efficient than 17POcap: con- 
centrations yielding 50% truncated fragments (C,J were 
about 2- to 4-fold higher for the phosphorothioate than 
for the phosphodiester oligonucleotide with both en- 
zymes (Table 2). cDNA synthesis was 50-80% abolished 
by a ratio of 4 oligonucleotides per RNA template 
(25 nM). 
At low concentration the effect was specific: below 100 
nM, neither 17POcap nor 17PScap led to a decrease in 
the overall cDNA synthesis. However, this was no longer 
true for 17PScap concentrations above 100 nM (see Fig. 
1). This was most likely due to a sequence-independent 
interaction between RT and the phosphorothioate oli- 
gomer, as previously described for the HIV RT [ 121. 
I”” 
I a) AMV RT I 
0 50 100 150 200 
a Oligonucleotide concentration (nM) 
Table 2 
Characteristics of 17POcap/RNA and 17PScap/RNA hybrids 
C,,, AMV (a’ Ciz MMLV’“’ T (dl 
(nM) (nM1 tO& 
17PScap 100 100 35 
17POcap 25 60 43 
The oligonucleotide concentration C,,r promoting 50% inhibition of 
cDNA synthesis (a), and the melting temperature (b) were determined 
as described in section 2, are indicated. 
3.3. Inhibition of cDNA synthesis results from an RNase 
H-mediated cleavage of the template 
We have previously shown that 17POcap leads to the 
cleavage of the RNA template by the RT-associated 
RNase H [ 131. We therefore looked for a similar cleavage 
produced in the presence of 17PScap. 
For this purpose, a 160 nt long fragment correspond- 
ing to the 5’ end of /?-globin mRNA was prepared, and 
probed by Northern blot analysis after reverse transcrip- 
tion, In the presence of the primer alone, fragments of 
about 130 nt long resulting from cleavage at the site of 
hybridization of the primer, were detected in addition to 
the intact RNA (Fig. 3). Upon addition of 17PScap, part 
of the 160 nt long RNA template was cleaved, generating 
truncated fragments shortened by about 20 nt (Fig. 3). 
These fragments were very likely due to the cleavage of 
the template region bound to 17PScap by the retroviral 
RNase H. The same fragments were detected when 
17POcap was used (Fig. 3). The efficiencies of reverse 
transcription inhibition by either 17POcap or 17PScap 
were roughly correlated with the cleavage efficiencies 
(*lo%), both with AMV (Fig. 2a) and MMLV RTs 
(Fig. 2b). This result indicates that the cleavage of the 
RNA template by RNase H is the major mechanism of 
inhibition. 
100 
b) MMLV FIT 
80 
1 
0 
1 
i 
60 - 
b ’ 50 100 150 200 Oligonucleotide concentration (nM) 
Fig. 2. Effect of antisense oligonucleotides on cDNA synthesis and template RNA. Reverse transcription by AMV (a) or MMLV (b) RTs was 
performed in the presence of either 17PCkap (o,o) or 17PScap @,o). Relative cDNA synthesis (o,@ and template RNA analysis (0,~) were carried 
out as indicated in section 2. 
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Enzyme : AMV MMLV 
Antisense : - 17PScap 17POcap - 17IPscap 17POcep 
M 24 150 30 150 M 1M 30 150 
Fig. 3. RNA template analysis by Northern blot after reverse transcrip- 
tion by AMV (left) or MMLV (right) RTs, in the absence (-) or 
presence of antisense oligonucleotides 17PScap and 17POcap, at the 
concentration (in nM) indicated at the top of the lanes. 
3.4. Inhibition of reverse transcription performed by an 
enzyme devoid of RNase H activity 
Due to the key role of RNase H in inducing the inhibi- 
tion of cDNA synthesis, we speculated that the use of an 
RT enzyme devoid of RNase H activity would abolish 
the antisense effect of 17PScap. Indeed, we had previ- 
ously reported that 17POcap did not arrest DNA synthe- 
sis by such an enzyme [ 131. We have used the MMLV RT 
devoid of RNase H activity (named MMLV H-) to check 
for the properties of 17PScap compared to that of 
17POcap. As illustrated in Fig. 4a, 17POcap did not lead 
to a detectable reduction in the amount of the 129 nt long 
cDNA fragment; in contrast, 17PScap significantly in- 
hibited cDNA synthesis by 20% at 50 nM and 38% at 100 
nM. A longer exposure of the autoradiography allowed 
the detection of fragments shorter than the full-length 
cDNA, the length of which (110 nt) indicated that 
MMLV H- RT had been stopped by the hybrid (Fig. 4b). 
These short fragments represented about 15% of the 
total cDNA synthesis at 100 nM 17POcap or 17PScap. 
Thus, hybridization of either 17POcap or 17PScap by 
itself can block the progression of the enzyme along the 
template and contribute to the overall inhibition of re- 
verse transcription. 
3.5. Stability of RNAIPO and RNAIPS hybrids 
A 21-mer RNA (21RNAsense) comprising the se- 
quence complementary to 17cap was prepared by tran- 
scription and incubated with equimolar amounts of 
17POcap or 17PScap. The stability of the resulting 
DNA/RNA hybrids was determined from melting curves 
as described in section 2. Melting temperatures (TJ were 
significantly different for the two hybrids: 43°C and 
35°C for RNAI17POcap and RNA/17PScap, respec- 
tively (Table 2). 
4. Discussion 
Phosphorothioate analogues, which are of high inter- 
est due to their combined nuclease resistance and capac- 
ity at eliciting RNase H activity, have been known for 
239 
several years as inhibitors of reverse transcription, essen- 
tially by a mechanism involving their binding to the en- 
zyme, i.e. by a process that is mostly sequence-independ- 
ent. Indeed, a number of phosphorothioate oligomers 
displayed anti-HIV activity, one of the most potent being 
the sulfur analogue of (dC),, [6]. 
In a previous study, we described the inhibition of 
reverse transcription by an unmodified antisense ol- 
igonucleotide (17POcap) using the /I-globin mRNA as a 
template [13]. We have clearly demonstrated here that 
the phosphorothioate oligonucleotide (17PScap) com- 
plementary to the same target was able to reduce cDNA 
synthesis by a true antisense effect, i.e. related to its 
hybridization to the complementary template sequence. 
The cleavage of the template strand by the RT-born 
RNase H activity accounted for most of the inhibition. 
However, a low level of hybrid-arrested cDNA synthesis 
was observed with both phosphorothioate and phospho- 
diester 17-mers when a recombinant RT devoid of 
RNase H activity (MMLV H-) was used. This phenom- 
enon has recently been observed for the inhibition of 
HIV RT-mediated reverse transcription by an unmod- 
ified oligomer [16], but had escaped our attention in a 
previous study [13] as it contributes only marginally to 
the antisense ffect. The parameters driving the relative 
level of RNase H-dependent and -independent mecha- 
nisms of inhibition are unclear as yet. However, for ol- 
igonucleotides able to mediate RNase H cleavage, this 
seems related to sequence/structure peculiarities of the 
antisense binding site rather than to the retroviral en- 
zyme. Indeed, results similar to those described here were 
obtained with 17PScap and 17POcap used against the 
rabbit @-globin mRNA reverse transcribed by the HIV 
enzyme (Boiziau et al., unpublished data). 
The comparison of the antisense fficacy of 17POcap 
and 17PScap showed that the former was a slightly better 
inhibitor. On the one hand, considering the RNA/anti- 
sense oligonucleotide duplexes, this could be related to 
the higher affinity of 17POcap for its RNA target, com- 
pared with 17PScap (Table 2) or to a greater sensitivity 
of RNA/PO- vs. RNA/PS-oligomer duplexes to RNase 
H- mediated cleavage. Indeed, such a difference was pre- 
viously described with human RNase H [24]. On the 
other hand, we still do not know what the active species 
Antisense : - 17IPscap 17POcap 
30 So 100 30 M lW 
- 17PS 17PO 
100 loo 
b) 
Fig. 4. Reverse transcription performed by MMLV H- RT, in absence 
(-) or presence of antisense oligonucleotides 17POcap or 17PScap, at 
the concentration indicated (in nM). The right part (b) is an overexpo- 
sure of the corresponding lanes given to the left (a). Size marker lengths 
(in nt) are indicated to the left. 
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inhibiting reverse transcription is: it may be a ternary 
hybrid formed by a non-polymerizing RT molecule sit- 
ting on the antisense/RNA duplex. The sites of elonga- 
tion arrest (and of RNase H-mediated cleavage) support 
this hypothesis. It is known that the polymerase site is 
operating about 15 nt ahead of the RNase H catalytic 
site [25]. It is therefore unlikely that the molecule elon- 
gating the cDNA strand is responsible for the cleavage 
of the template bound to the antisense oligomer. Conse- 
quently, in addition to the stability of RNA/antisense 
duplexes and to the capacity of the antisense to elicit an 
RNase H- mediated cleavage of the RNA template, the 
antisense fficacy would also be related to the affinity of 
RT for the duplex. 
In a recent paper, Hatta and co-workers [26] used 
exactly the same combination of RNA template, primer 
and antisense oligonucleotides as the one used in our 
previous paper [13] and in this one, to investigate the 
effect of 17PScap on reverse transcription. In contrast to 
our results, they concluded that inhibition occured only 
via the binding of the oligomer to the AMV RT. Despite 
the poor quality of their autoradiographs, it seems that 
a shortened cDNA species, indicative of a sequence-de- 
pendent effect, can be detected (see Fig. 2a in [26]). How- 
ever, the high concentrations of oligonucleotide they 
used (>l ,uM) prevented them from demonstrating antis- 
ense effects. 
In conclusion we have demonstrated that phospho- 
rothioate oligonucleotides can inhibit the reverse tran- 
scription by hybridization to the RNA template. This 
could in part be responsible for the inhibition of HIV 
development either in de novo or in chronically infected 
cultured cells. 
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